Early Phase 1 Endometriosis Trial, Recruiting (NCT03746535)

Early Phase 1 Endometriosis Trial, Recruiting NCT03746535 Sponsor: Yale University Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT03746535 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women between the ages of 18 and 45 who do not have endometriosis (as a comparison/control group)
Women between the ages of 18 and 45 who have been diagnosed with endometriosis

Who may not be able to join:

People who currently smoke
People who have diabetes
People who have sleep apnea or have blood pressure higher than 140/90
Women with endometriosis who are experiencing severe, sudden pain that needs immediate medical attention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Nina Stachenfeld, MD, Yale University

Phone: 203-562-9901

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03746535

Sponsor: Yale University

Phase: Early Phase 1

Status: Recruiting

Condition: Endometriosis

Trial contact: 203-562-9901

More information: https://clinicaltrials.gov/study/NCT03746535

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women between the ages of 18 and 45 who do not have endometriosis (as a comparison/control group)
Women between the ages of 18 and 45 who have been diagnosed with endometriosis

Who may not be able to join:

People who currently smoke
People who have diabetes
People who have sleep apnea or have blood pressure higher than 140/90
Women with endometriosis who are experiencing severe, sudden pain that needs immediate medical attention

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

Yale University

Registry

ClinicalTrials.gov

Start date

1 July 2022

Est. completion

1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Flow Mediated Vasodilation Microvascular skin blood flow analysis; Microdialysis perfusions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov